Please provide your email address to receive an email when new articles are posted on . Lymphopenia at diagnosis or during follow-up can predict OS among patients with multiple myeloma. Researchers ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window NATIONAL HARBOR, ...
While Epogen and Neupogen addresses anemia and neutropenia, no therapy has existed for the treatment of lymphopenia until ANKTIVA® –The Cancer BioShield. Landmark overall survival benefit (P-value ...
The prognostic significance of exosomal markers (CD63 and CD9) expression using immunohistochemistry in patients with pancreatic ductal adenocarcinoma. A randomized phase II clinical trial of ...
Building External Control Arms From Patient-Level Electronic Health Record Data to Replicate the Randomized IMblaze370 Control Arm in Metastatic Colorectal Cancer A single-institution retrospective ...
Lower levels of lymphocyte blood cells -- a condition called lymphopenia -- could be an early warning for future illness, as low counts were associated with a 60% increase in death from any cause, ...
Authorized expanded access for ANKTIVA to treat lymphopenia, a life-threatening immune deficiency induced by chemotherapy, radiotherapy, and immunotherapy with depletion of natural killer (NK) and ...
Despite the use of modern immunochemotherapy regimens, almost 50% of patients with diffuse large-B-cell lymphoma will relapse. Current prognostic models, including the International Prognostic Index, ...
Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. A low lymphocyte count in people presenting to the hospital with COVID-19 could help physicians ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback